ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Rituximab Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-2Y15964
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Rituximab Injection Market Research Report 2023
BUY CHAPTERS

Global Recombinant Rituximab Injection Market Research Report 2025

Code: QYRE-Auto-2Y15964
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Pfizer Inc
Amgen Inc
Celltrion Healthcare
Henlius
Innovent Biologics

Recombinant Rituximab Injection Market Size

The global market for Recombinant Rituximab Injection was valued at US$ 1464 million in the year 2024 and is projected to reach a revised size of US$ 1932 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Recombinant Rituximab Injection Market

Recombinant Rituximab Injection Market

Recombinant Rituximab Injection is a medication used for the treatment of various medical conditions, particularly certain types of cancer and autoimmune diseases. Rituximab is a monoclonal antibody, and the recombinant version is produced using biotechnology methods to create a synthetic, highly targeted form of the drug.
Recombinant Rituximab Injection is a significant biopharmaceutical product widely used for the treatment of various autoimmune diseases and malignant tumors. The market for this product is substantial and continuously growing due to the increasing demand for healthcare. In the future, it is expected that this field will continue to evolve, with specific uses of Rituximab Injection potentially expanding to include the treatment of more autoimmune diseases, presenting additional business opportunities in the biopharmaceutical industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Rituximab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Rituximab Injection.
The Recombinant Rituximab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Rituximab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Rituximab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Rituximab Injection Market Report

Report Metric Details
Report Name Recombinant Rituximab Injection Market
Accounted market size in year US$ 1464 million
Forecasted market size in 2031 US$ 1932 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 100mg
  • 500mg
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Pfizer, Amgen, Celltrion Healthcare, Henlius, Innovent Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Rituximab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Rituximab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Rituximab Injection Market growing?

Ans: The Recombinant Rituximab Injection Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Recombinant Rituximab Injection Market size in 2031?

Ans: The Recombinant Rituximab Injection Market size in 2031 will be US$ 1932 million.

Who are the main players in the Recombinant Rituximab Injection Market report?

Ans: The main players in the Recombinant Rituximab Injection Market are Roche, Pfizer, Amgen, Celltrion Healthcare, Henlius, Innovent Biologics

What are the Application segmentation covered in the Recombinant Rituximab Injection Market report?

Ans: The Applications covered in the Recombinant Rituximab Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Recombinant Rituximab Injection Market report?

Ans: The Types covered in the Recombinant Rituximab Injection Market report are 100mg, 500mg

Recommended Reports

Monoclonal Antibody Drugs

Recombinant & Injection

Autoimmune & Cancer Therapies

1 Recombinant Rituximab Injection Market Overview
1.1 Product Definition
1.2 Recombinant Rituximab Injection by Type
1.2.1 Global Recombinant Rituximab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg
1.2.3 500mg
1.3 Recombinant Rituximab Injection by Application
1.3.1 Global Recombinant Rituximab Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Rituximab Injection Market Size Estimates and Forecasts
1.4.1 Global Recombinant Rituximab Injection Revenue 2020-2031
1.4.2 Global Recombinant Rituximab Injection Sales 2020-2031
1.4.3 Global Recombinant Rituximab Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Rituximab Injection Market Competition by Manufacturers
2.1 Global Recombinant Rituximab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Rituximab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Rituximab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Rituximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Rituximab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Rituximab Injection, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Rituximab Injection, Date of Enter into This Industry
2.8 Global Recombinant Rituximab Injection Market Competitive Situation and Trends
2.8.1 Global Recombinant Rituximab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Rituximab Injection Players Market Share by Revenue
2.8.3 Global Recombinant Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Rituximab Injection Market Scenario by Region
3.1 Global Recombinant Rituximab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Rituximab Injection Sales by Region: 2020-2031
3.2.1 Global Recombinant Rituximab Injection Sales by Region: 2020-2025
3.2.2 Global Recombinant Rituximab Injection Sales by Region: 2026-2031
3.3 Global Recombinant Rituximab Injection Revenue by Region: 2020-2031
3.3.1 Global Recombinant Rituximab Injection Revenue by Region: 2020-2025
3.3.2 Global Recombinant Rituximab Injection Revenue by Region: 2026-2031
3.4 North America Recombinant Rituximab Injection Market Facts & Figures by Country
3.4.1 North America Recombinant Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Rituximab Injection Sales by Country (2020-2031)
3.4.3 North America Recombinant Rituximab Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Rituximab Injection Market Facts & Figures by Country
3.5.1 Europe Recombinant Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Rituximab Injection Sales by Country (2020-2031)
3.5.3 Europe Recombinant Rituximab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Rituximab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Rituximab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Rituximab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Rituximab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Rituximab Injection Market Facts & Figures by Country
3.7.1 Latin America Recombinant Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Rituximab Injection Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Rituximab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Rituximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Rituximab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Rituximab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Rituximab Injection Sales by Type (2020-2031)
4.1.1 Global Recombinant Rituximab Injection Sales by Type (2020-2025)
4.1.2 Global Recombinant Rituximab Injection Sales by Type (2026-2031)
4.1.3 Global Recombinant Rituximab Injection Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Rituximab Injection Revenue by Type (2020-2031)
4.2.1 Global Recombinant Rituximab Injection Revenue by Type (2020-2025)
4.2.2 Global Recombinant Rituximab Injection Revenue by Type (2026-2031)
4.2.3 Global Recombinant Rituximab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Rituximab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Rituximab Injection Sales by Application (2020-2031)
5.1.1 Global Recombinant Rituximab Injection Sales by Application (2020-2025)
5.1.2 Global Recombinant Rituximab Injection Sales by Application (2026-2031)
5.1.3 Global Recombinant Rituximab Injection Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Rituximab Injection Revenue by Application (2020-2031)
5.2.1 Global Recombinant Rituximab Injection Revenue by Application (2020-2025)
5.2.2 Global Recombinant Rituximab Injection Revenue by Application (2026-2031)
5.2.3 Global Recombinant Rituximab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Rituximab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Recombinant Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Recombinant Rituximab Injection Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Recombinant Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Recombinant Rituximab Injection Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Company Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Recombinant Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Amgen Recombinant Rituximab Injection Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Celltrion Healthcare
6.4.1 Celltrion Healthcare Company Information
6.4.2 Celltrion Healthcare Description and Business Overview
6.4.3 Celltrion Healthcare Recombinant Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Celltrion Healthcare Recombinant Rituximab Injection Product Portfolio
6.4.5 Celltrion Healthcare Recent Developments/Updates
6.5 Henlius
6.5.1 Henlius Company Information
6.5.2 Henlius Description and Business Overview
6.5.3 Henlius Recombinant Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Henlius Recombinant Rituximab Injection Product Portfolio
6.5.5 Henlius Recent Developments/Updates
6.6 Innovent Biologics
6.6.1 Innovent Biologics Company Information
6.6.2 Innovent Biologics Description and Business Overview
6.6.3 Innovent Biologics Recombinant Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Innovent Biologics Recombinant Rituximab Injection Product Portfolio
6.6.5 Innovent Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Rituximab Injection Industry Chain Analysis
7.2 Recombinant Rituximab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Rituximab Injection Production Mode & Process Analysis
7.4 Recombinant Rituximab Injection Sales and Marketing
7.4.1 Recombinant Rituximab Injection Sales Channels
7.4.2 Recombinant Rituximab Injection Distributors
7.5 Recombinant Rituximab Injection Customer Analysis
8 Recombinant Rituximab Injection Market Dynamics
8.1 Recombinant Rituximab Injection Industry Trends
8.2 Recombinant Rituximab Injection Market Drivers
8.3 Recombinant Rituximab Injection Market Challenges
8.4 Recombinant Rituximab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Pfizer Inc
Amgen Inc
Celltrion Healthcare
Henlius
Innovent Biologics
List of Tables
 Table 1. Global Recombinant Rituximab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Rituximab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Rituximab Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Rituximab Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Rituximab Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Rituximab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Rituximab Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Rituximab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Rituximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Rituximab Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Rituximab Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Rituximab Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Rituximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Rituximab Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Rituximab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Rituximab Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Rituximab Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Rituximab Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Rituximab Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Rituximab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Rituximab Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Rituximab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Rituximab Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Rituximab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Rituximab Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Rituximab Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Rituximab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Rituximab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Rituximab Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Rituximab Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Rituximab Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Rituximab Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Rituximab Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Rituximab Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Rituximab Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Rituximab Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Rituximab Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Rituximab Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Rituximab Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Rituximab Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Rituximab Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Rituximab Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Rituximab Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Rituximab Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Rituximab Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Rituximab Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Rituximab Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Rituximab Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Recombinant Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Recombinant Rituximab Injection Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Recombinant Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Recombinant Rituximab Injection Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Amgen Company Information
 Table 81. Amgen Description and Business Overview
 Table 82. Amgen Recombinant Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Amgen Recombinant Rituximab Injection Product
 Table 84. Amgen Recent Developments/Updates
 Table 85. Celltrion Healthcare Company Information
 Table 86. Celltrion Healthcare Description and Business Overview
 Table 87. Celltrion Healthcare Recombinant Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Celltrion Healthcare Recombinant Rituximab Injection Product
 Table 89. Celltrion Healthcare Recent Developments/Updates
 Table 90. Henlius Company Information
 Table 91. Henlius Description and Business Overview
 Table 92. Henlius Recombinant Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Henlius Recombinant Rituximab Injection Product
 Table 94. Henlius Recent Developments/Updates
 Table 95. Innovent Biologics Company Information
 Table 96. Innovent Biologics Description and Business Overview
 Table 97. Innovent Biologics Recombinant Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Innovent Biologics Recombinant Rituximab Injection Product
 Table 99. Innovent Biologics Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Recombinant Rituximab Injection Distributors List
 Table 103. Recombinant Rituximab Injection Customers List
 Table 104. Recombinant Rituximab Injection Market Trends
 Table 105. Recombinant Rituximab Injection Market Drivers
 Table 106. Recombinant Rituximab Injection Market Challenges
 Table 107. Recombinant Rituximab Injection Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Rituximab Injection
 Figure 2. Global Recombinant Rituximab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Rituximab Injection Market Share by Type: 2024 & 2031
 Figure 4. 100mg Product Picture
 Figure 5. 500mg Product Picture
 Figure 6. Global Recombinant Rituximab Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Rituximab Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Recombinant Rituximab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Rituximab Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Rituximab Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Rituximab Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Rituximab Injection Report Years Considered
 Figure 16. Recombinant Rituximab Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Rituximab Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Rituximab Injection Players: Market Share by Revenue in Recombinant Rituximab Injection in 2024
 Figure 19. Recombinant Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Rituximab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Rituximab Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Rituximab Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Recombinant Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Recombinant Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Recombinant Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Recombinant Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Recombinant Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Recombinant Rituximab Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Recombinant Rituximab Injection by Type (2020-2031)
 Figure 53. Global Recombinant Rituximab Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Recombinant Rituximab Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Rituximab Injection by Application (2020-2031)
 Figure 56. Global Recombinant Rituximab Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Recombinant Rituximab Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Rituximab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rituximab Biosimilars Market Research Report 2025
Rituximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rituximab Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rituxan rituximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antibody Market Research Report 2025
Biosimilars of Rituximab Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rituxan Rituximab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Protein Peptide Drug Market Research Report 2024
Rituxan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Emicizumab Injection Market Research Report 2024
Rituxan Rituximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infliximab Injection Market Research Report 2024
Global Recombinant Rabbit Monoclonal Antibodies Market Research Report 2025
Global IL 17 Monoclonal Antibody Injections Market Research Report 2024
Global Recombinant Protein Drug R D Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Recombinant Streptokinase for Injection Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions